Company: NCEL
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065783
Chunk: 76

Company: NewcelX Ltd.
Filing Date: 2025-07-18
Form: F-4/A
Chunk 76
---
 for intellectual property maintenance costs of up to $100,000 per calendar year), the combined company will have the right to cease the sale process of the divested business and take any action regarding it as deemed appropriate. The rights of the holders and the obligations of NLS are contract rights limited to those expressly set forth in the Merger Agreement and the CVR Agreement, and such holders’ sole right to receive property thereunder is the right to receive cash received from the sale of the Legacy Assets, if any, through the Rights Agent in accordance with the terms of the Merger Agreement and the CVR Agreement. For a more detailed description, see “ Risk Factors — Risks Related to the Merger,”and “Certain related Agreements — CVR Agreement.” xi

Q.Can I sell the CVRs? No. The CVRs cannot be sold or transferred other than through a permitted transfer. For a more complete description of the transferability of the CVRs, please see the section entitled “ Certain Related Agreements — CVR Agreement” in this proxy statement/prospectus. Q.Who will be the directors of NLS following the Merger? At and immediately after the Effective Time of the Merger, subject to the approval of NLS shareholders, the NLS Board is expected to be composed of the individuals set forth in the table below. The directors shall serve until their respective successors are duly elected or appointed and qualified or their earlier death, resignation or removal.

| Name                        |     | Age |     | Position(s)                                            |
| Ronen Twito                 |     |  50 |     | Executive Chairman nominee and Chief Executive Officer |
| Prof. Michel Revel, MD, PhD |     |  86 |     | Director nominee and Chief Scientific Officer          |
| Olivier Samuel              |     |  51 |     | Independent Director                                   |
| Eran Iohan                  |     |  54 |     | Independent Director nominee                           |
| Liora Oren                  |     |  47 |     | Independent Director nominee                           |
| Alexander C. Zwyer          |     |  56 |     | Director                                               |
| Tammy Galili                |     |  53 |     | Director nominee                                       |

Q.Who will be the executive officers of NLS immediately following the Merger? Immediately following the Merger, the executive officers’ team of NLS is expected to be composed as set forth below:

| Name                        |     | Age |     | Position(s) with